Revenue Concentration - For the year ended December 31, 2025, two customers within the Healthcare Segment represented 12.2% and 11.4% of the company's revenue, respectively[39]. - The company expects to maintain relationships with key customers that have historically contributed significant revenue percentages[39]. Intellectual Property - The company held 854 patents worldwide as of December 31, 2025, down from 1,247 patents in 2024, and had 258 pending patent applications[48]. Workforce and Employment - The company had 1,418 full-time and part-time employees as of December 31, 2025, a decrease from 1,833 employees in 2024[64]. - The company provides substantial safety training and necessary equipment at all facilities to ensure employee safety and health[70]. - The company is committed to creating a safe work environment, focusing on reducing significant safety risks and driving a strong safety culture through training and awareness[70]. - The company emphasizes the importance of monitoring injury and illness metrics to evaluate the effectiveness of safety programs[70]. Research and Development - The company is engaged in R&D efforts related to regenerative medicine, including 3D printing technologies for transplantable organs[46]. - The company has ongoing R&D programs to develop new products and enhance its portfolio, including internally and externally funded initiatives[45]. Business Strategy - The company’s go-to-market strategy includes a direct sales force and channel partners, with a focus on comprehensive design to manufacturing solutions[36]. - The company aims to maintain a competitive edge through innovation, quality, and exceptional customer service, supported by a robust supply chain[52]. - The company’s sustainability strategy is organized into four pillars, including empowering innovation and evolving the future of manufacturing[58]. - The company’s production facilities are located in the U.S. and Europe, focusing on in-sourcing manufacturing to improve quality and cost efficiency[41]. Executive Team - The executive team includes Jeffrey A. Graves as President and CEO, Phyllis Nordstrom as Interim CFO, and Charles W. Hull as Chief Technology Officer, among others[74][75][76]. - Phyllis Nordstrom was appointed as Interim Chief Financial Officer effective September 2025, bringing extensive experience in corporate compliance and risk management[75]. - The executive team has a diverse background, with experience in various industries including technology, engineering, and corporate governance[74][75][76][78][79]. - Charles W. Hull has been with the company since its founding and has served in various executive roles, including Chief Technology Officer since 1997[76]. - Reji Puthenveetil has transitioned to Chief Commercial Officer in January 2024, previously leading Industrial Solutions[77]. - Joseph Zuiker has been Executive Vice President of Engineering and Operations since December 2022, with a strong background in engineering and operations[78]. - Andrew W. B. Wright serves as Senior Vice President, General Counsel and Secretary, bringing extensive legal experience from previous roles in technology companies[79].
3D Systems(DDD) - 2025 Q4 - Annual Report